Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00459342
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2007-04-09
Brief Title:
Dasatinib in Treating Patients With Stage IIIB Stage IV or Recurrent Non-Small Cell Lung Cancer
Sponsor:
Organization:
National Cancer Institute NCI